• 2502 Citations
  • 23 h-Index
1994 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Research Output

2020
Open Access
1 Citation (Scopus)
2019

AGTR1 aptamer-anticancer drug complex for cancer cell chemotherapy

Seo, J. H., 2019 Feb 5, Patent No. 10195285

Research output: Patent

A pilot study on intermittent every other days of 5-dose Filgrastim compared with single Pegfilgrastim in breast Cancer patients receiving adjuvant Docetaxel, doxorubicin, and cyclophosphamide (TAC) chemotherapy

Sohn, B. S., Jeong, J. H., Ahn, J. H., Jung, K. H., Kim, J. E., Sohn, J. H., Koh, S. J., Seo, J. H., Lee, K. S. & Kim, S. B., 2019 Jan 1, (Accepted/In press) In : Investigational New Drugs.

Research output: Contribution to journalArticle

C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition

Cho, T. M., Kim, J. Y., Kim, Y. J., Sung, D., Oh, E., Jang, S., Farrand, L., Hoang, V. H., Nguyen, C. T., Ann, J., Lee, J. & Seo, J. H., 2019 Apr 10, In : Cancer Letters. 447, p. 141-153 13 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Efficacy, Safety, and Tolerability of Pertuzumab, Trastuzumab, and Docetaxel for Patients with Early or Locally Advanced ERBB2-Positive Breast Cancer in Asia: The PEONY Phase 3 Randomized Clinical Trial

Shao, Z., Pang, D., Yang, H., Li, W., Wang, S., Cui, S., Liao, N., Wang, Y., Wang, C., Chang, Y. C., Wang, H., Kang, S. Y., Seo, J. H., Shen, K., Laohawiriyakamol, S., Jiang, Z., Li, J., Zhou, J., Althaus, B., Mao, Y. & 1 others, Eng-Wong, J., 2019 Jan 1, (Accepted/In press) In : JAMA Oncology.

Research output: Contribution to journalArticle

2 Citations (Scopus)
Open Access

Investigation of B,C-ring truncated deguelin derivatives as heat shock protein 90 (HSP90) inhibitors for use as anti-breast cancer agents

Kim, H. S., Hoang, V. H., Hong, M., Chul Kim, K., Ann, J., Nguyen, C. T., Seo, J. H., Choi, H., Yong Kim, J., Kim, K. W., Sub Byun, W., Lee, S., Lee, S., Suh, Y. G., Chen, J., Park, H. J., Cho, T. M., Kim, J. Y., Seo, J. H. & Lee, J., 2019 Apr 1, In : Bioorganic and Medicinal Chemistry. 27, 7, p. 1370-1381 12 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)

Pluronics: Intelligent building units for targeted cancer therapy and molecular imaging

Khaliq, N. U., Park, D. Y., Yun, B. M., Yang, D. H., Jung, Y. W., Seo, J. H., Hwang, C. S. & Yuk, S. H., 2019 Feb 10, In : International Journal of Pharmaceutics. 556, p. 30-44 15 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
Open Access
2018

AGTR1 aptamer-anticancer drug complex for cancer cell chemotherapy

Seo, J. H., 2018 Nov 23, Patent No. 10-1923624

Research output: Patent

Current Strategies of Endocrine Therapy in Elderly Patients with Breast Cancer

Lee, S. Y. & Seo, J. H., 2018 Jan 1, In : BioMed Research International. 2018, 6074808.

Research output: Contribution to journalReview article

3 Citations (Scopus)

Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition

Oh, E., Kim, Y. J., An, H., Sung, D., Cho, T. M., Farrand, L., Jang, S., Seo, J. H. & Kim, J. Y., 2018 Jan 1, (Accepted/In press) In : International Journal of Cancer.

Research output: Contribution to journalArticle

17 Citations (Scopus)

Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer

Kim, Y. J., Sung, D., Oh, E., Cho, Y., Cho, T. M., Farrand, L., Seo, J. H. & Kim, J. Y., 2018 Jan 1, In : Cancer Letters. 412, p. 118-130 13 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

HER-2 targeted aptamer complex and use thereof

Seo, J. H., 2018 Nov 27, Patent No. 10137203

Research output: Patent

Nucleic Acid Aptamer Specifically Binding to Angiotensin II Type I Receptor

Seo, J. H., 2018 Oct 22, Patent No. 10-1912174

Research output: Patent

Pluronic/Heparin Nanoparticles for Chemo-Photodynamic Combination Cancer Therapy through Photoinduced Caspase-3 Activation

Khaliq, N. U., Park, D. Y., Lee, H. J., Oh, K. S., Seo, J. H., Kim, S. Y., Hwang, C. S., Lim, T. H. & Yuk, S. H., 2018 Jun 22, In : ACS Applied Nano Materials. 1, 6, p. 2943-2952 10 p.

Research output: Contribution to journalArticle

5 Citations (Scopus)
1 Citation (Scopus)
2017

An open-label, randomized, parallel, phase III trial evaluating the efficacy and safety of polymeric micelle-formulated paclitaxel compared to conventional Cremophor EL-Based paclitaxel for recurrent or metastatic HER2-negative breast cancer

Park, I. H., Sohn, J. H., Kim, S. B., Lee, K. S., Chung, J. S., Lee, S. H., Kim, T. Y., Jung, K. H., Cho, E. K., Kim, Y. S., Song, H. S., Seo, J. H., Ryoo, H. M., Lee, S. A., Yoon, S. Y., Kim, C. S., Kim, Y. T., Kim, S. Y., Jin, M. R. & Ro, J., 2017 Jul 1, In : Cancer Research and Treatment. 49, 3, p. 569-577 9 p.

Research output: Contribution to journalArticle

22 Citations (Scopus)

Assembly of polymer micelles through the sol-gel transition for effective cancer therapy

Khaliq, N. U., Oh, K. S., Sandra, F. C., Joo, Y., Lee, J., Byun, Y., Kim, I-S., Kwon, I. C., Seo, J. H., Kim, S. Y. & Yuk, S. H., 2017 Jun 10, In : Journal of Controlled Release. 255, p. 258-269 12 p.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Disulfiram induces anoikis and suppresses lung colonization in triple-negative breast cancer via calpain activation

Kim, J. Y., Lee, N., Kim, Y. J., Cho, Y., An, H., Oh, E., Cho, T. M., Sung, D. & Seo, J. H., 2017 Feb 1, In : Cancer Letters. 386, p. 151-160 10 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Disulfiram suppresses cancer stem-like properties and STAT3 signaling in triple-negative breast cancer cells

Kim, Y. J., Kim, J. Y., Lee, N., Oh, E., Sung, D., Cho, T. M. & Seo, J. H., 2017 May 13, In : Biochemical and Biophysical Research Communications. 486, 4, p. 1069-1076 8 p.

Research output: Contribution to journalArticle

17 Citations (Scopus)

Feasibility and efficacy of eribulin mesilate in Korean patients with metastatic breast cancer: Korean multi-center phase IV clinical study results

Park, Y. H., Kim, T. Y., Im, Y. H., Lee, K. S., Park, I. H., Sohn, J., Lee, S. H., Im, S. A., Kim, J. H., Kim, S. H., Lee, S. J., Koh, S. J., Lee, K. H., Choi, Y. J., Cho, E. K., Lee, S., Kang, S. Y., Seo, J. H., Kim, S. B. & Jung, K. H., 2017 Apr 1, In : Cancer Research and Treatment. 49, 2, p. 423-429 7 p.

Research output: Contribution to journalArticle

4 Citations (Scopus)

Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells

Oh, E., Kim, J. Y., Sung, D., Cho, Y., Lee, N., An, H., Kim, Y. J., Cho, T. M. & Seo, J. H., 2017 Aug 1, In : Cellular Signalling. 36, p. 230-239 10 p.

Research output: Contribution to journalArticle

8 Citations (Scopus)
114 Citations (Scopus)
4 Citations (Scopus)
12 Citations (Scopus)

Ulmus davidiana Nakai induces apoptosis and autophagy on non-small cell lung cancer cells

Hong, S. O., Choi, I. K., Jeong, W., Lee, S. R., Sung, H. J., Hong, S. & Seo, J. H., 2017 Apr 18, In : Journal of Ethnopharmacology. 202, p. 1-11 11 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2016

A randomized, multi-center, open-label, phase III study of once-per-cycle DA-3031, a pegylated G-CSF, in comparison with daily filgrastim in patients receiving TAC chemotherapy for breast cancer

Park, K. H., Lee, S., Park, J. H., Kang, S. Y., Kim, H. Y., Park, I. H., Park, Y. H., Im, Y. H., Lee, H. J., Park, S., Lee, S. I., Jung, K. H., Kim, Y. S. & Seo, J. H., 2016 Oct 6, (Accepted/In press) In : Supportive Care in Cancer. p. 1-7 7 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)

Caveolin-1 modulates docetaxel-induced cell death in breast cancer cell subtypes through different mechanisms

Kang, J., Park, J. H., Lee, H. J., Jo, U., Park, J. K., Seo, J. H., Kim, Y. H., Kim, I. & Park, K. H., 2016 Apr 1, In : Cancer Research and Treatment. 48, 2, p. 715-726 12 p.

Research output: Contribution to journalArticle

10 Citations (Scopus)

Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer

Kim, J. Y., Cho, Y., Oh, E., Lee, N., An, H., Sung, D., Cho, T. M. & Seo, J. H., 2016 Aug 28, In : Cancer Letters. 379, 1, p. 39-48 10 p.

Research output: Contribution to journalArticle

21 Citations (Scopus)

Docetaxel-loaded multilayer nanoparticles with nanodroplets for cancer therapy

Oh, K. S., Kim, K., Yoon, B. D., Lee, H. J., Park, D. Y., Kim, E. Y., Lee, K., Seo, J. H. & Yuk, S. H., 2016 Mar 16, In : International Journal of Nanomedicine. 11, p. 1077-1087 11 p.

Research output: Contribution to journalArticle

9 Citations (Scopus)

Erratum to: Vaccination with ErbB-2 peptides prevents cancer stem cell expansion and suppresses the development of spontaneous tumors in MMTV-PyMT transgenic mice (Breast Cancer Res Treat, (2014), 147, 69-80, 10.1007/s10549-014-3086-4)

Gil, E. Y., Jo, U. H., Lee, H. J., Kang, J., Seo, J. H., Lee, E. S., Kim, Y. H., Kim, I. S., Phan-Lai, V., Disis, M. L. & Park, K. H., 2016 Feb 1, In : Breast Cancer Research and Treatment. 155, 3, p. 617-618 2 p.

Research output: Contribution to journalComment/debate

HER-2 targeted aptamer complex and use thereof

Seo, J. H., 2016 Aug 26, Patent No. 10-1653451

Research output: Patent

Incidence and Predictors of Febrile Neutropenia among Early-Stage Breast Cancer Patients Receiving Anthracycline-Based Chemotherapy in Korea

Kim, H. S., Lee, S. Y., Kim, J. W., Choi, Y. J., Park, I. H., Lee, K. S., Seo, J. H., Shin, S. W., Kim, Y. H., Kim, J. S. & Park, K. H., 2016 Sep 14, (Accepted/In press) In : Oncology (Switzerland). p. 274-282 9 p.

Research output: Contribution to journalArticle

2 Citations (Scopus)

Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis

Oh, E., Kim, J. Y., Cho, Y., An, H., Lee, N., Jo, H., Ban, C. & Seo, J. H., 2016 Jun 1, In : Biochimica et Biophysica Acta - Molecular Cell Research. 1863, 6, p. 1071-1081 11 p.

Research output: Contribution to journalArticle

23 Citations (Scopus)

Pregnancy-Associated risk factors of postpartum breast cancer in korea: A nationwide health insurance database study

Kang, E. J., Seo, J. H., Kim, L. Y., Park, G. U., Oh, M. J., Park, P. J. & Cho, G-J., 2016 Dec 1, In : PLoS One. 11, 12, e0168469.

Research output: Contribution to journalArticle

11 Citations (Scopus)

Prognostic Factors and Skeletal-Related Events in Patients with Small Cell Lung Cancer with Bone Metastases at the Time of Diagnosis

Kang, E. J., Lee, S. Y., Kim, H. J., Min, K-H., Hur, G. Y., Shim, J. J., Kang, K. H., Oh, S. C., Seo, J. H., Lee, S. Y. & Kim, J. S., 2016 Feb 1, In : Oncology (Switzerland). 90, 2, p. 103-111 9 p.

Research output: Contribution to journalArticle

13 Citations (Scopus)

Safety and efficacy of single-agent docetaxel (Taxotere) administered weekly in non-small cell lung carcinoma patients in Korea: An observational study

Lim, S. M., Park, B. B., Park, K. C., Kim, H. K., Lee, J. S., Bae, S. H., Lee, S. S., Kang, J. H., Park, S. H., Lee, G. W., Lee, H. R., Seo, J. H., Kim, Y. T., Yang, S. H. & Kim, J. H., 2016 Mar 1, In : Thoracic Cancer. 7, 2, p. 207-214 8 p.

Research output: Contribution to journalArticle

1 Citation (Scopus)
2015
6 Citations (Scopus)
12 Citations (Scopus)

Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway

An, H., Kim, J. Y., Lee, N., Cho, Y., Oh, E. & Seo, J. H., 2015 Oct 30, In : Biochemical and Biophysical Research Communications. 466, 4, p. 696-703 8 p.

Research output: Contribution to journalArticle

19 Citations (Scopus)

Salinomycin promotes anoikis and decreases the CD44+/CD24- stem-like population via inhibition of STAT3 activation in MDA-MB-231 cells

An, H., Kim, J. Y., Oh, E., Lee, N., Cho, Y. & Seo, J. H., 2015 Nov 3, In : PLoS One. 10, 11, e0141919.

Research output: Contribution to journalArticle

45 Citations (Scopus)

Targeting stemness is an effective strategy to control EML4-ALK+ non-small cell lung cancer cells

Oh, S. J., Noh, K. H., Lee, Y. H., Hong, S. O., Song, K. H., Lee, H. J., Kim, S., Kim, T. M., Jeon, J. H., Seo, J. H., Kim, D. W. & Kim, T. W., 2015, In : Oncotarget. 6, 37, p. 40255-40267 13 p.

Research output: Contribution to journalArticle

12 Citations (Scopus)

The siRNA cocktail targeting interleukin 10 receptor and transforming growth factor-β receptor on dendritic cells potentiates tumour antigen-specific CD8<sup>+</sup> T cell immunity

Ahn, Y. H., Hong, S. O., Kim, J. H., Noh, K. H., Song, K. H., Lee, Y. H., Jeon, J. H., Kim, D. W., Seo, J. H. & Kim, T. W., 2015 Jul 1, In : Clinical and Experimental Immunology. 181, 1, p. 164-178 15 p.

Research output: Contribution to journalArticle

29 Citations (Scopus)
2014

Accurate sequential detection of primary tumor and metastatic lymphatics using a temperature-induced phase transition nanoparticulate system

Oh, K. S., Yhee, J. Y., Lee, D. E., Kim, K. M., Kwon, I. C., Seo, J. H., Kim, S. Y. & Yuk, S. H., 2014 Jun 18, In : International Journal of Nanomedicine. 9, 1, p. 2955-2965 11 p.

Research output: Contribution to journalArticle

3 Citations (Scopus)
11 Citations (Scopus)

Case report of pulmonary sarcoidosis suspected to be pulmonary metastasis in a patient with breast cancer

Kim, H. S., Lee, S. Y., Oh, S. C., Choi, C. W., Kim, J. S. & Seo, J. H., 2014 Jan 1, In : Cancer Research and Treatment. 46, 3, p. 317-321 5 p.

Research output: Contribution to journalArticle

7 Citations (Scopus)